Cargando…
Variability of forced vital capacity in progressive interstitial lung disease: a prospective observational study
BACKGROUND: Fibrotic interstitial lung disease (ILD) is often associated with poor outcomes, but has few predictors of progression. Daily home spirometry has been proposed to provide important information about the clinical course of idiopathic pulmonary disease (IPF). However, experience is limited...
Autores principales: | Veit, Tobias, Barnikel, Michaela, Crispin, Alexander, Kneidinger, Nikolaus, Ceelen, Felix, Arnold, Paola, Munker, Dieter, Schmitzer, Magdalena, Barton, Jürgen, Schiopu, Sanziana, Schiller, Herbert B., Frankenberger, Marion, Milger, Katrin, Behr, Jürgen, Neurohr, Claus, Leuschner, Gabriela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574190/ https://www.ncbi.nlm.nih.gov/pubmed/33076914 http://dx.doi.org/10.1186/s12931-020-01524-8 |
Ejemplares similares
-
Clinical Impact of Physical Activity and Cough on Disease Progression in Fibrotic Interstitial Lung Disease
por: Veit, Tobias, et al.
Publicado: (2023) -
Domestic Parasitic Infections in Patients with Asthma and Eosinophilia in Germany – Three Cases with Learnings in the Era of Anti- IL5 Treatments
por: Barnikel, Michaela, et al.
Publicado: (2023) -
Riociguat in Patients with CTEPH and Advanced Age and/or Comorbidities
por: Barnikel, Michaela, et al.
Publicado: (2022) -
Real‐life effectiveness of biological therapies on symptoms in severe asthma with comorbid CRSwNP
por: Mümmler, Carlo, et al.
Publicado: (2021) -
Pulmonary function impairment of asymptomatic and persistently symptomatic patients 4 months after COVID-19 according to disease severity
por: Munker, Dieter, et al.
Publicado: (2021)